1.19 +0.04 (3.67%)
CYTR
Stock Details
Last Trade:1.19 Change:+0.04 (3.67%) Prev Close:1.15 Open: 1.09 Days Range:1.09 – 1.19 52 Week Range: 0.23 - 1.21 Volume:870425 P/E: N/AEPS:-0.27
View AllRecent Alerts 07/04/09
Recent Alert on 06/30/09 at 8:35am
CytRx (CYTR) Files Response to FDA On Partial Clinical Hold On Phase 2b Arimoclomol ALS Trial
CytRx (CYTR) Files Response to FDA On Partial Clinical Hold On Phase 2b Arimoclomol ALS Trial
CytRx Corporation (NASDAQ: CYTR) filed a report with the FDA in response to the Agency's partial clinical hold on the Company’s Phase 2b efficacy clinical trial with its molecular chaperone regulator drug candidate arimoclomol for the treatment of... Read More
Recent Alert on 06/29/09 at 9:17am
DCGN, CYTR, IOC, TRW, SVA, WEN See Volume and Upside Price Action
DCGN, CYTR, IOC, TRW, SVA, WEN See Volume and Upside Price Action
Recent Alert on 06/29/09 at 9:14am
Morning Movers 6/29: PHC, RNN, DCGN, CYTR, ARTX Higher; UEC, RMTI, ENP, CTIC, OPEN Lower
Morning Movers 6/29: PHC, RNN, DCGN, CYTR, ARTX Higher; UEC, RMTI, ENP, CTIC, OPEN Lower
Recent Alert on 06/29/09 at 8:47am
CytRx (CYTR) Reports Favorable Progress Update for Ongoing Phase 2 STAR-1 Trial of Tamibarotene
CytRx (CYTR) Reports Favorable Progress Update for Ongoing Phase 2 STAR-1 Trial of Tamibarotene
Recent Alert on 06/25/09 at 9:30am
Morning Movers 6/25: JAZZ, CAEI, CYTR, TWB, XRTX, CAR Higher; INSM, ACXM, GRO, TCK, RHT Lower
Morning Movers 6/25: JAZZ, CAEI, CYTR, TWB, XRTX, CAR Higher; INSM, ACXM, GRO, TCK, RHT Lower
View AllRecent Press Releases
Press Release on 06/30/09 at 8:30am
CytRx Files Report with the FDA in Response to the Partial Clinical Hold on its Phase 2b Arimoclomol ALS Trial
CytRx Files Report with the FDA in Response to the Partial Clinical Hold on its Phase 2b Arimoclomol ALS Trial
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 07/01/09 at 4:48am
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG